Chang An Hui Tong Fund
VC Fund
Xian Shi, China
Chang An Hui Tong Fund is a VC fund in Xian Shi focused on Medical and Biopharma. Chang'an Huitong is the provincial state-owned capital operation company in the province approved by the provincial government.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 60%
Last updated:
For AI agents: llms.txt
Industries Chang An Hui Tong Fund invests in
Stages Chang An Hui Tong Fund invests in
Countries Chang An Hui Tong Fund invests in
Investment Focus
Industry
- Medical 2 (40%)
- Biopharma 1 (20%)
- Health Care 1 (20%)
- Biotechnology 1 (20%)
- Manufacturing 1 (20%)
Stage
- Series C 2 (40%)
- Series A 1 (20%)
- Series B 1 (20%)
- Venture - Series Unknown 1 (20%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Shaanxi Xifeng Liquor
|
Shaanxi Xifeng Liquor Co,.LTD is a flavored liquor manufacturing company. | $68.7M / Venture - Series Unknown / Aug 05, 2024 | |
Bio Regenmed
|
Bioregeneration is a national high-tech industrial firm that creates and manufactures innovative biomedical materials with the goal of human tissue engineering and organ repair. | Series C / Dec 28, 2023 | |
|
ECHINT
|
ECHINT is a global advanced semiconductor packaging and testing services technology company that offers customers with one-stop packaging and testing services and solutions such as packaging design, chip packaging, and testing. | $137.3M / Series B / Aug 18, 2023 | |
Feidie XR Technology
|
Feidie XR Technology help users quickly create XR content and multi-person interactive Metaverse applications without coding. | Series A / Feb 13, 2023 | |
Micot
|
Micot is a new molecular entity drug developer for peptides, dedicated to the development of innovative drugs, multi- and protein-based innovative biopharmaceuticals, vaccines and biomolecular drug delivery systems and products, and for drug screening and biopharmaceutical research. The technology combines to provide users with Bio-Res-Deliv, abiological macromolecular respiratory drug delivery system, suitable for the treatment of cardiovascular diseases, metabolic diseases, liver diseases and the like. | $14.7M / Series C / Feb 10, 2023 |
Co-Investors
Chengdu Science and Technology Venture Capital
1 deal together
Infore Capital
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Chang An Hui Tong Fund invest in?
Chang An Hui Tong Fund invests primarily in Medical, Biopharma and Health Care startups, most often at Series C and Series A stage. Most of the 5 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Chang An Hui Tong Fund last invest?
The most recent investment recorded for Chang An Hui Tong Fund closed in Aug 2024. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
